陶沙

  • 个人介绍
  • 教学与科研情况
  • 获奖情况
  • 职    称: 青年副研究员(硕士生导师)
  • 所属部门: 预防医学教研室
  • 联系方式: 021-54237356
  • 电子邮件: taosha@fudan.edu.cn

研究方向

陶沙,博士。2002年毕业于哈尔滨医科大学,于2006年英国伦敦大学玛丽女王学院(Queen Mary, University of London)获得硕士学位,2012年于德国海德堡大学取得流行病学博士学位。2009年至2013年间就职于德国癌症研究中心(DKFZ),一直致力于结肠癌早期诊断方法的研究,在国际知名期刊发表研究论文10余篇。2013年底作为引进人才加入复旦大学公共卫生学院,主要研究方向是疾病的筛查,健康的风险度评估与干预和健康管理。

学术简历

Publications:

  • 1. Surinova S, Choi M, Tao S, Schüffler PJ, Chang CY, Clough T, et al. Prediction of colorectal cancer diagnosis based on circulating plasma proteins. EMBO Mol Med. 2015;7(9):1166-78.
  • 2. von Winterfeld M, Hoffmeister M, Ingold-Heppner B, Jansen L, Tao S, Herpel E, et al. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition. Eur J Cancer. 2014;50(17):2958-65. 
  • 3. Bläker H, Hildebrandt B, Riess H, von Winterfeld M, Ingold-Heppner B, Roth W, et al. Lymph node count and prognosis in colorectal cancer: the influence of examination quality. Int J Cancer. 2015;136(8):1957-66.
  • 4. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol. 2014;12(3):478-85.
  • 5. Dihlmann S, Tao S, Echterdiek F, Herpel E, Jansen L, Chang-Claude J, et al. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients. Int J of Cancer. 2014;135(10):2387-96.
  • 6. Werner S, Chen H, Tao S, Brenner H. Systematic review: serum autoantibodies in the early detection of gastric cancer. Int J Cancer. 2015;136(10):2243-52.
  • 7. Chen H, Werner S, Tao S, Zornig  I, Brenner H. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Cancer Letters. 2014;346(2):178-87.
  • 8. Gerola S, Nittka S, Kahler G, Tao S, Brenner H, Binelli G, et al. Genetic variants in apoptosis-related genes associated with colorectal hyperplasia. Genes Chromosomes Cancer. 2014;53(9):769-78.
  • 9. Brenner H, Tao S. Superior diagnostic performance of fecal immunochemical tests for hemoglobin in a head-to-head comparison with guaiac based fecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49(14):3049-54.
  • 10. Tao S, SeilerC, Ronellenfitsch U, Brenner H. Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer. Acta Oncol 2013;52(8):1667-75. 
  • 11. Tao S, Brenner H. Well-adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening. Eur J Cancer Prev. 2013;22(4):305-10.
  • 12. Brenner H, Altenhofen L, Tao S. Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests. J Clin Epidemiol. 2013;66(2):202-8.
  • 13. Tao S, Haug U, Kuhn K, Brenner H. Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening. Br J Cancer. 2012;106:1424-30.
  • 14. Tao S, Hundt S, Haug U, Brenner H. Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease. Am J Gastroenterol. 2011;106:242-53.
  • 15. Luo X, Burwinkel B, Tao S, Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev. 2011;20:1272-86.
  • 16. Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304:2513-20.
  • 17. Tao S, Croucher RE, Pau AK. Smoking prevalence, attitudes and behaviour of Chinese dental students. Int Dent J. 2008;58(4):181-6.

社会兼职

Review Editor the Editorial Board of Cancer Epidemiology and Prevention,a specialty of Frontiers in Oncology.